Predicting Alzheimer's disease phenotypes with aging clocks: an exploratory analysis
Cindy David Sarmento, Gabin Drouard, Toni Tapani Saari…·Eero Vuoksimaa
This study explores proteomic and epigenetic aging clocks as biomarkers for Alzheimer's disease phenotypes, finding proteomic clocks improve explained variance in cognitive and biomarker measures by up to 18%.